BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 [PMID: 34887643 DOI: 10.3748/wjg.v27.i43.7462]
URL: https://www.wjgnet.com/1949-8470/full/v27/i43/7462.htm
Number Citing Articles
1
Nojan Bajestani, Gavin Wu, Ahmed Hussein, Mina S. Makary. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular CarcinomaBiomedicines 2024; 12(7): 1432 doi: 10.3390/biomedicines12071432
2
Guorong Jia, Tao Wang, Rou Li, Xiao Li, Gaofeng Sun, Wei Chen, Ye Peng, Chao Cheng, Jijin Yang, Changjing Zuo. Radioiodine‐131‐Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver TumorAdvanced Healthcare Materials 2023; 12(32) doi: 10.1002/adhm.202301559
3
Cody R Criss, Mina S Makary. Salvage locoregional therapies for recurrent hepatocellular carcinomaWorld Journal of Gastroenterology 2023; 29(3): 413-424 doi: 10.3748/wjg.v29.i3.413
4
Ronald S. Arellano. Complications Associated with Image-Guided Percutaneous Thermal Ablation of Liver TumorsDigestive Disease Interventions 2023; 7(03): 180 doi: 10.1055/s-0042-1760372
5
John Domini, Mina S. Makary. Single-center analysis of percutaneous ablation in the treatment of hepatocellular carcinoma: long-term outcomes of a 7-year experienceAbdominal Radiology 2023;  doi: 10.1007/s00261-023-03819-y
6
Yanjun Gao, Yingge Li, Zheming Liu, Yi Dong, Siqi Yang, Bin Wu, Mengxia Xiao, Chen Chen, Yingmei Wen, Lei Chen, Haijuan Jiang, Yi Yao. AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 PathwayJournal of Hepatocellular Carcinoma 2023; : 2021 doi: 10.2147/JHC.S407680
7
Lauren Matevish, Madhukar S. Patel, Parsia A. Vagefi. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver TransplantationSurgical Clinics of North America 2024; 104(1): 145 doi: 10.1016/j.suc.2023.07.004
8
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translationJournal of Controlled Release 2024; 367: 737 doi: 10.1016/j.jconrel.2024.01.072
9
Piaoyi Chen, Qinglin Xiao, Zhaoxiong Guo, Wei Liang, Ou Liu, Liteng Lin, Yugang Huang, Kangshun Zhu, Guodong Ye. Synthesis and characterization of 3-in-1 multifunctional lipiodol-doped Fe3O4@Poly (diallyl isophthalate) microspheres for arterial embolization, chemotherapy, and imagingBiomedical Materials 2024; 19(3): 035011 doi: 10.1088/1748-605X/ad2c1a
10
Luca Grisetti, Clarissa J. C. Garcia, Anna A. Saponaro, Claudio Tiribelli, Devis Pascut. The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancerCell Proliferation 2024;  doi: 10.1111/cpr.13641
11
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalitiesWorld Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
12
Nadine Abi-Jaoudeh, Ben Sadeghi, Hanna Javan, Jim Na, Graham Beaton, Fabio Tucci, Satheesh Ravula, David K. Imagawa. Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 ModelCancers 2023; 15(12): 3236 doi: 10.3390/cancers15123236
13
Andrei M. Jipa, Mina S. Makary. Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel ApplicationsCancers 2024; 16(7): 1271 doi: 10.3390/cancers16071271
14
Warren A. Campbell, Jeffrey F. B. Chick, David S. Shin, Mina S. Makary. Value of interventional radiology and their contributions to modern medical systemsFrontiers in Radiology 2024; 4 doi: 10.3389/fradi.2024.1403761
15
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti, Alessandro Uzzau. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and PrognosisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897703
16
Maryam Farzaneh, Majid Ghasemian, Farhoodeh Ghaedrahmati, Jafar Poodineh, Sajad Najafi, Tariq Masoodi, Dedy Kurniawan, Shahab Uddin, Shirin Azizidoost. Functional roles of lncRNA-TUG1 in hepatocellular carcinomaLife Sciences 2022; 308: 120974 doi: 10.1016/j.lfs.2022.120974
17
Long-Bin Jeng, Wen-Ling Chan, Chiao-Fang Teng. Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular CarcinomaCancers 2023; 15(4): 1005 doi: 10.3390/cancers15041005
18
Elliott L. Fite, Mina S. Makary. Transarterial Chemoembolization Treatment Paradigms for Hepatocellular CarcinomaCancers 2024; 16(13): 2430 doi: 10.3390/cancers16132430
19
Pan Liu, Xu Zhang, Qiang Fu, ChuanJiang Liu, QianKun Luo, PengFei Yu, Song Chen, HongWei Zhang, Tao Qin, Yuanwei Zhang. LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA DamageDisease Markers 2022; 2022: 1 doi: 10.1155/2022/9313680
20
Kassem Sharif, Adi Lahat, Idan Levy, Shomron Ben Horin. Gastric Perforation After Microwave Ablation to Adjacent Hepatocellular LesionACG Case Reports Journal 2023; 10(6): e01082 doi: 10.14309/crj.0000000000001082
21
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, Yingmin Yao, Wen Sun, Qiancheng Ma, Dongsheng Huang, Qiuran Xu. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-MycBiochemical and Biophysical Research Communications 2023; 638: 210 doi: 10.1016/j.bbrc.2022.11.046
22
Warren A. Campbell, Mina S. Makary. Advances in Image-Guided Ablation Therapies for Solid TumorsCancers 2024; 16(14): 2560 doi: 10.3390/cancers16142560
23
Attila Kovács, Peter Bischoff, Hathal Haddad, Willi Zhou, Susanne Temming, Andreas Schäfer, Hannah Spallek, Lucas Kaupe, György Kovács, Michael Pinkawa. Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver MalignanciesJournal of Personalized Medicine 2022; 12(3): 430 doi: 10.3390/jpm12030430
24
Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim. Early-Stage HCC Percutaneous Locoregional Management: East versus West PerspectivesCancers 2023; 15(15): 3988 doi: 10.3390/cancers15153988
25
Yuming Shi, Erfan Taherifard, Ali Saeed, Anwaar Saeed. MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment OptionsCurrent Issues in Molecular Biology 2024; 46(6): 5965 doi: 10.3390/cimb46060356
26
Xiaoying Xu, Yu Liu, Yanyan Liu, Yahan Yu, Mingqi Yang, Ligong Lu, Leung Chan, Bing Liu. Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro modelJournal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02547-9
27
Marine Soret, Jacques-Antoine Maisonobe, Philippe Maksud, Stéphane Payen, Manon Allaire, Eric Savier, Charles Roux, Charlotte Lussey-Lepoutre, Aurélie Kas. Feasibility of Liver Transplantation after 90Y Radioembolization: Lessons from a Radiation Protection IncidentHealth Physics 2024;  doi: 10.1097/HP.0000000000001814
28
Sarah B. White, Dilip Rajasekhar Maddirela. Hepatobiliary Cancers: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2023; 3: 255 doi: 10.1007/16833_2022_122
29
Josua A. Decker, Christian Scheurig-Muenkler, Jan H. Luitjens, Thomas Kroencke. Nationwide Trends and the Influence of Age and Gender in the In-Patient Care of Patients with Hepatocellular Carcinoma in Germany between 2010 and 2020Cancers 2023; 15(10): 2792 doi: 10.3390/cancers15102792
30
Yitong Li, Ruihang Zhang, Zhen Xu, Zhicheng Wang. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver CancerInternational Journal of Nanomedicine 2022; : 909 doi: 10.2147/IJN.S349426